Skip to main content
Tulane Home Tulane Home

Research in Real Time

PR landing page feature


Diamonds, those precious, sparkling jewels, are known as the hardest materials on Earth. They are a high-pressure form of carbon and found deep in the ground.

While diamonds are commonly thought of as hard and stable, carbon from about 100 miles beneath the African plate is being...

PR landing page feature

Jun 02, 2020 - Carolyn Scofield

Researchers at Tulane University School of Medicine identified a gene that causes an aggressive form of breast cancer to rapidly grow.  More importantly, they have also discovered a way to “turn it off” and inhibit cancer from occurring.  The animal study results have been so compelling that the team is now working on FDA approval to begin clinical trials and has published details in the journal Scientific Reports.

May 13, 2020 - Keith Brannon

Macrophages are a type of white blood cell central to the immune system. They detect harmful pathogens – viruses, bacteria, and fungi – and engulf them, serving as helpful scavengers to keep infections at bay. They also cause or suppress inflammation and secrete molecules that allow communication between different cell types, all which provide a healthy immune response in fighting any infection or disease.

May 08, 2020 - Carolyn Scofield

Three Tulane University researchers are the recipients of new Fast Grants, awards designed to quickly fund COVID-19 related projects. Mairi Noverr, Monica Vaccari and Tracy Fischer received a total of $350,000 for their proposals, all of which progressed from mere proposals to fully funded projects in just 48 hours.

Apr 24, 2020 - Sharon Lurye

The U.S. Department of Education’s Institute of Education Sciences has awarded the National Center for Research on Education Access and Choice (REACH) at Tulane University a $100,000 contract to collect data from approximately 150,000 school websites across the country to see how the nation’s education system is responding to the coronavirus pandemic.


Apr 22, 2020 - Keith Brannon

Researchers at Tulane University are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.